{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,20]],"date-time":"2026-09-20T19:31:26Z","timestamp":1789932686242,"version":"4.0.1"},"reference-count":203,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2020,3,17]],"date-time":"2020-03-17T00:00:00Z","timestamp":1584403200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2020,3,17]],"date-time":"2020-03-17T00:00:00Z","timestamp":1584403200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"Sir Henry Dale Fellowship","award":["105636\/Z\/14\/Z"],"award-info":[{"award-number":["105636\/Z\/14\/Z"]}]},{"DOI":"10.13039\/501100000272","name":"National Institute for Health Research","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000272","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Rev Endocr Metab Disord"],"published-print":{"date-parts":[[2020,12]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>\n                    Hyperinsulinemic hypoglycemia (HH) is characterized by unregulated insulin release, leading to persistently low blood glucose concentrations with lack of alternative fuels, which increases the risk of neurological damage in these patients. It is the most common cause of persistent and recurrent hypoglycemia in the neonatal period. HH may be primary, Congenital HH (CHH), when it is associated with variants in a number of genes implicated in pancreatic development and function. Alterations in fifteen genes have been recognized to date, being some of the most recently identified mutations in genes\n                    <jats:italic>HK1, PGM1, PMM2, CACNA1D, FOXA2<\/jats:italic>\n                    and\n                    <jats:italic>EIF2S3<\/jats:italic>\n                    . Alternatively, HH can be secondary when associated with syndromes, intra-uterine growth restriction, maternal diabetes, birth asphyxia, following gastrointestinal surgery, amongst other causes. CHH can be histologically characterized into three groups: diffuse, focal or atypical. Diffuse and focal forms can be determined by scanning using fluorine-18 dihydroxyphenylalanine-positron emission tomography. Newer and improved isotopes are currently in development to provide increased diagnostic accuracy in identifying lesions and performing successful surgical resection with the ultimate aim of curing the condition. Rapid diagnostics and innovative methods of management, including a wider range of treatment options, have resulted in a reduction in co-morbidities associated with HH with improved quality of life and long-term outcomes. Potential future developments in the management of this condition as well as pathways to transition of the care of these highly vulnerable children into adulthood will also be discussed.\n                  <\/jats:p>","DOI":"10.1007\/s11154-020-09548-7","type":"journal-article","created":{"date-parts":[[2020,3,17]],"date-time":"2020-03-17T05:03:40Z","timestamp":1584421420000},"page":"577-597","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":81,"title":["Hyperinsulinemic hypoglycemia in children and adolescents: Recent advances in understanding of pathophysiology and management"],"prefix":"10.1007","volume":"21","author":[{"given":"Maria","family":"G\u03cbemes","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sofia Asim","family":"Rahman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ritika R.","family":"Kapoor","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarah","family":"Flanagan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jayne A. L.","family":"Houghton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shivani","family":"Misra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nick","family":"Oliver","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mehul Tulsidas","family":"Dattani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4402-8297","authenticated-orcid":false,"given":"Pratik","family":"Shah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,3,17]]},"reference":[{"issue":"4","key":"9548_CR1","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1007\/s001250051322","volume":"43","author":"B Ahr\u00e9n","year":"2000","unstructured":"Ahr\u00e9n B. Autonomic regulation of islet hormone secretion--implications for health and disease. Diabetologia. 2000;43(4):393\u2013410.","journal-title":"Diabetologia"},{"issue":"4","key":"9548_CR2","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1007\/s10545-011-9441-2","volume":"35","author":"S Senniappan","year":"2012","unstructured":"Senniappan S, Shanti B, James C, Hussain K. Hyperinsulinaemic hypoglycaemia: genetic mechanisms, diagnosis and management. J Inherit Metab Dis. 2012;35(4):589\u2013601.","journal-title":"J Inherit Metab Dis"},{"key":"9548_CR3","doi-asserted-by":"crossref","unstructured":"Chinoy, A. et  al. \u2018Focal congenital hyperinsulinism as a cause for sudden infant death\u2019. Pediatr Dev Pathol. 2019;22(1):65\u201369.","DOI":"10.1177\/1093526618765376"},{"issue":"5","key":"9548_CR4","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1016\/j.annpat.2017.07.003","volume":"37","author":"A Guyot","year":"2017","unstructured":"Guyot A, Moreau F, Eberhard M, Gaulier JM, Paraf F. Congenital hyperinsulinism revealed by sudden infant death. Ann Pathol. 2017;37(5):429\u201332.","journal-title":"Ann Pathol"},{"key":"9548_CR5","doi-asserted-by":"crossref","first-page":"60","DOI":"10.3389\/fendo.2013.00060","volume":"4","author":"HB Avatapalle","year":"2013","unstructured":"Avatapalle HB, et al. Abnormal neurodevelopmental outcomes are common in children with transient congenital Hyperinsulinism. Front Endocrinol (Lausanne). 2013;4:60.","journal-title":"Front Endocrinol (Lausanne)"},{"key":"9548_CR6","doi-asserted-by":"crossref","unstructured":"G\u00fcemes M, Rahman SA, Hussain K. What is a normal blood glucose? Arch Dis Child. 2016;101:569\u2013574.","DOI":"10.1136\/archdischild-2015-308336"},{"issue":"2","key":"9548_CR7","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1016\/j.jpeds.2015.03.057","volume":"167","author":"PS Thornton","year":"2015","unstructured":"Thornton PS, Stanley CA, de Leon DD, Harris D, Haymond MW, Hussain K, et al. Recommendations from the pediatric Endocrine Society for evaluation and Management of Persistent Hypoglycemia in neonates, infants, and children. J Pediatr. 2015;167(2):238\u201345.","journal-title":"J Pediatr"},{"issue":"1","key":"9548_CR8","first-page":"2","volume":"69","author":"K Hussain","year":"2008","unstructured":"Hussain K. Diagnosis and management of hyperinsulinaemic hypoglycaemia of infancy. Horm Res. 2008;69(1):2\u201313.","journal-title":"Horm Res"},{"key":"9548_CR9","doi-asserted-by":"crossref","unstructured":"Patel P, Charles L, Corbin J, et al. A unique allosteric insulin receptor monoclonal antibody that prevents hypoglycemia in the SUR-1-\/-\u00a0mouse model of KATP hyperinsulinism.\u00a0MAbs. 2018;10(5):796\u2013802.\u00a0","DOI":"10.1080\/19420862.2018.1457599"},{"key":"9548_CR10","doi-asserted-by":"crossref","unstructured":"Arya VB, Mohammed Z, Blankenstein O, de Lonlay P, Hussain K. Hyperinsulinaemic hypoglycaemia. Horm Metab Res. 2014;46(3):157\u201370.","DOI":"10.1055\/s-0034-1367063"},{"key":"9548_CR11","doi-asserted-by":"crossref","unstructured":"Vannucci RC, Vannucci SJ. Hypoglycemic brain injury. Semin Neonatol. 2001;6(2):147\u201355.","DOI":"10.1053\/siny.2001.0044"},{"key":"9548_CR12","doi-asserted-by":"crossref","unstructured":"Hussain K, et al. An activating mutation of AKT2 and human hypoglycemia. Science. 2011;334(6055):474.","DOI":"10.1126\/science.1210878"},{"key":"9548_CR13","doi-asserted-by":"crossref","unstructured":"Staufner C, Lindner M, Dionisi-Vici C, Freisinger P, Dobbelaere D, Douillard C, et al. Adenosine kinase deficiency: expanding the clinical spectrum and evaluating therapeutic options. J Inherit Metab Dis. 2016;39(2):273\u201383.","DOI":"10.1007\/s10545-015-9904-y"},{"key":"9548_CR14","doi-asserted-by":"crossref","unstructured":"Gillis D, Krishnamohan A, Yaacov B, Shaag A, Jackman JE, Elpeleg O. TRMT10A dysfunction is associated with abnormalities in glucose homeostasis, short stature and microcephaly. J Med Genet. 2014;51(9):581\u20136.","DOI":"10.1136\/jmedgenet-2014-102282"},{"issue":"1","key":"9548_CR15","doi-asserted-by":"crossref","first-page":"19","DOI":"10.4103\/2230-8210.107822","volume":"17","author":"S Senniappan","year":"2013","unstructured":"Senniappan S, Arya VB, Hussain K. The molecular mechanisms, diagnosis and management of congenital hyperinsulinism. Indian J Endocrinol Metab. 2013;17(1):19\u201330.","journal-title":"Indian J Endocrinol Metab"},{"issue":"5239","key":"9548_CR16","doi-asserted-by":"crossref","first-page":"1166","DOI":"10.1126\/science.270.5239.1166","volume":"270","author":"N Inagaki","year":"1995","unstructured":"Inagaki N, et al. Reconstitution of IKATP: an inward rectifier subunit plus the sulfonylurea receptor. Science. 1995;270(5239):1166\u201370.","journal-title":"Science"},{"issue":"4","key":"9548_CR17","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1530\/EJE-12-0673","volume":"168","author":"RR Kapoor","year":"2013","unstructured":"Kapoor RR, et al. Clinical and molecular characterisation of 300 patients with congenital hyperinsulinism. Eur J Endocrinol. 2013;168(4):557\u201364.","journal-title":"Eur J Endocrinol"},{"issue":"5209","key":"9548_CR18","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1126\/science.7716548","volume":"268","author":"PM Thomas","year":"1995","unstructured":"Thomas PM, Cote GJ, Wohllk N, Haddad B, Mathew PM, Rabl W, et al. Mutations in the sulfonylurea receptor gene in familial persistent hyperinsulinemic hypoglycemia of infancy. Science. 1995;268(5209):426\u20139.","journal-title":"Science"},{"issue":"11","key":"9548_CR19","doi-asserted-by":"crossref","first-page":"1809","DOI":"10.1093\/hmg\/5.11.1809","volume":"5","author":"P Thomas","year":"1996","unstructured":"Thomas P, Ye Y, Lightner E. Mutation of the pancreatic islet inward rectifier Kir6.2 also leads to familial persistent hyperinsulinemic hypoglycemia of infancy. Hum Mol Genet. 1996;5(11):1809\u201312.","journal-title":"Hum Mol Genet"},{"issue":"19","key":"9548_CR20","doi-asserted-by":"crossref","first-page":"17139","DOI":"10.1074\/jbc.M200363200","volume":"277","author":"G Taschenberger","year":"2002","unstructured":"Taschenberger G, Mougey A, Shen S, Lester LB, LaFranchi S, Shyng SL. Identification of a familial hyperinsulinism-causing mutation in the sulfonylurea receptor 1 that prevents normal trafficking and function of KATP channels. J Biol Chem. 2002;277(19):17139\u201346.","journal-title":"J Biol Chem"},{"issue":"2","key":"9548_CR21","doi-asserted-by":"crossref","first-page":"E207","DOI":"10.1152\/ajpendo.00047.2002","volume":"283","author":"H Huopio","year":"2002","unstructured":"Huopio H, et al. K(ATP) channels and insulin secretion disorders. Am J Physiol Endocrinol Metab. 2002;283(2):E207\u201316.","journal-title":"Am J Physiol Endocrinol Metab"},{"issue":"7","key":"9548_CR22","doi-asserted-by":"crossref","first-page":"897","DOI":"10.1172\/JCI9804","volume":"106","author":"H Huopio","year":"2000","unstructured":"Huopio H, Reimann F, Ashfield R, Komulainen J, Lenko HL, Rahier J, et al. Dominantly inherited hyperinsulinism caused by a mutation in the sulfonylurea receptor type 1. J Clin Invest. 2000;106(7):897\u2013906.","journal-title":"J Clin Invest"},{"issue":"9354","key":"9548_CR23","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1016\/S0140-6736(03)12325-2","volume":"361","author":"H Huopio","year":"2003","unstructured":"Huopio H, Otonkoski T, Vauhkonen I, Reimann F, Ashcroft FM, Laakso M. A new subtype of autosomal dominant diabetes attributable to a mutation in the gene for sulfonylurea receptor 1. Lancet. 2003;361(9354):301\u20137.","journal-title":"Lancet"},{"issue":"6","key":"9548_CR24","doi-asserted-by":"crossref","first-page":"582","DOI":"10.1111\/j.1399-0004.2010.01476.x","volume":"79","author":"SE Flanagan","year":"2011","unstructured":"Flanagan SE, Kapoor RR, Banerjee I, Hall C, Smith VV, Hussain K, et al. Dominantly acting ABCC8 mutations in patients with medically unresponsive hyperinsulinaemic hypoglycaemia. Clin Genet. 2011;79(6):582\u20137.","journal-title":"Clin Genet"},{"issue":"8","key":"9548_CR25","doi-asserted-by":"crossref","first-page":"2877","DOI":"10.1172\/JCI35414","volume":"118","author":"SE Pinney","year":"2008","unstructured":"Pinney SE, MacMullen C, Becker S, Lin YW, Hanna C, Thornton P, et al. Clinical characteristics and biochemical mechanisms of congenital hyperinsulinism associated with dominant KATP channel mutations. J Clin Invest. 2008;118(8):2877\u201386.","journal-title":"J Clin Invest"},{"issue":"10","key":"9548_CR26","doi-asserted-by":"crossref","first-page":"2575","DOI":"10.1007\/s00125-011-2207-4","volume":"54","author":"RR Kapoor","year":"2011","unstructured":"Kapoor RR, et al. Hyperinsulinaemic hypoglycaemia and diabetes mellitus due to dominant ABCC8\/KCNJ11 mutations. Diabetologia. 2011;54(10):2575\u201383.","journal-title":"Diabetologia"},{"issue":"19","key":"9548_CR27","doi-asserted-by":"crossref","first-page":"1352","DOI":"10.1056\/NEJM199805073381904","volume":"338","author":"CA Stanley","year":"1998","unstructured":"Stanley CA, et al. Hyperinsulinism and hyperammonemia in infants with regulatory mutations of the glutamate dehydrogenase gene. N Engl J Med. 1998;338(19):1352\u20137.","journal-title":"N Engl J Med"},{"issue":"4","key":"9548_CR28","doi-asserted-by":"crossref","first-page":"667","DOI":"10.2337\/diabetes.49.4.667","volume":"49","author":"CA Stanley","year":"2000","unstructured":"Stanley CA, Fang J, Kutyna K, Hsu BY, Ming JE, Glaser B, et al. Molecular basis and characterization of the hyperinsulinism\/hyperammonemia syndrome: predominance of mutations in exons 11 and 12 of the glutamate dehydrogenase gene. HI\/HA Contributing Investigators. Diabetes. 2000;49(4):667\u201373.","journal-title":"Diabetes"},{"issue":"5","key":"9548_CR29","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1530\/EJE-09-0615","volume":"161","author":"RR Kapoor","year":"2009","unstructured":"Kapoor RR, Flanagan SE, Fulton P, Chakrapani A, Chadefaux B, Ben-Omran T, et al. Hyperinsulinism-hyperammonaemia syndrome: novel mutations in the GLUD1 gene and genotype-phenotype correlations. Eur J Endocrinol. 2009;161(5):731\u20135.","journal-title":"Eur J Endocrinol"},{"issue":"4","key":"9548_CR30","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1056\/NEJM199801223380404","volume":"338","author":"B Glaser","year":"1998","unstructured":"Glaser B, et al. Familial hyperinsulinism caused by an activating glucokinase mutation. N Engl J Med. 1998;338(4):226\u201330.","journal-title":"N Engl J Med"},{"issue":"1","key":"9548_CR31","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1530\/EJE-08-0203","volume":"159","author":"HB Christesen","year":"2008","unstructured":"Christesen HB, et al. Activating glucokinase (GCK) mutations as a cause of medically responsive congenital hyperinsulinism: prevalence in children and characterisation of a novel GCK mutation. Eur J Endocrinol. 2008;159(1):27\u201334.","journal-title":"Eur J Endocrinol"},{"issue":"8","key":"9548_CR32","doi-asserted-by":"crossref","first-page":"2164","DOI":"10.2337\/diabetes.53.8.2164","volume":"53","author":"AL Cuesta-Munoz","year":"2004","unstructured":"Cuesta-Munoz AL, et al. Severe persistent hyperinsulinemic hypoglycemia due to a de novo glucokinase mutation. Diabetes. 2004;53(8):2164\u20138.","journal-title":"Diabetes"},{"issue":"4","key":"9548_CR33","doi-asserted-by":"crossref","first-page":"1240","DOI":"10.2337\/diabetes.51.4.1240","volume":"51","author":"HB Christesen","year":"2002","unstructured":"Christesen HB, Jacobsen BB, Odili S, Buettger C, Cuesta-Munoz A, Hansen T, et al. The second activating glucokinase mutation (A456V): implications for glucose homeostasis and diabetes therapy. Diabetes. 2002;51(4):1240\u20136.","journal-title":"Diabetes"},{"key":"9548_CR34","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1186\/1750-1172-7-25","volume":"7","author":"AJ Heslegrave","year":"2012","unstructured":"Heslegrave AJ, et al. Leucine-sensitive hyperinsulinaemic hypoglycaemia in patients with loss of function mutations in 3-Hydroxyacyl-CoA dehydrogenase. Orphanet J Rare Dis. 2012;7:25.","journal-title":"Orphanet J Rare Dis"},{"issue":"1","key":"9548_CR35","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1016\/j.bbrc.2007.10.188","volume":"368","author":"C Filling","year":"2008","unstructured":"Filling C, Keller B, Hirschberg D, Marschall HU, J\u00f6rnvall H, Bennett MJ, et al. Role of short-chain hydroxyacyl CoA dehydrogenases in SCHAD deficiency. Biochem Biophys Res Commun. 2008;368(1):6\u201311.","journal-title":"Biochem Biophys Res Commun"},{"issue":"3","key":"9548_CR36","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1172\/JCI200111294","volume":"108","author":"PT Clayton","year":"2001","unstructured":"Clayton PT, et al. Hyperinsulinism in short-chain L-3-hydroxyacyl-CoA dehydrogenase deficiency reveals the importance of beta-oxidation in insulin secretion. J Clin Invest. 2001;108(3):457\u201365.","journal-title":"J Clin Invest"},{"issue":"1","key":"9548_CR37","doi-asserted-by":"crossref","first-page":"221","DOI":"10.2337\/diabetes.53.1.221","volume":"53","author":"A Molven","year":"2004","unstructured":"Molven A, Matre GE, Duran M, Wanders RJ, Rishaug U, Nj\u00f8lstad PR, et al. Familial hyperinsulinemic hypoglycemia caused by a defect in the SCHAD enzyme of mitochondrial fatty acid oxidation. Diabetes. 2004;53(1):221\u20137.","journal-title":"Diabetes"},{"issue":"7","key":"9548_CR38","doi-asserted-by":"crossref","first-page":"2221","DOI":"10.1210\/jc.2009-0423","volume":"94","author":"RR Kapoor","year":"2009","unstructured":"Kapoor RR, James C, Flanagan SE, Ellard S, Eaton S, Hussain K. 3-Hydroxyacyl-coenzyme a dehydrogenase deficiency and hyperinsulinemic hypoglycemia: characterization of a novel mutation and severe dietary protein sensitivity. J Clin Endocrinol Metab. 2009;94(7):2221\u20135.","journal-title":"J Clin Endocrinol Metab"},{"issue":"3","key":"9548_CR39","doi-asserted-by":"crossref","first-page":"E498","DOI":"10.1210\/jc.2010-1906","volume":"96","author":"SE Flanagan","year":"2011","unstructured":"Flanagan SE, et al. Genome-wide homozygosity analysis reveals HADH mutations as a common cause of diazoxide-responsive hyperinsulinemic-hypoglycemia in consanguineous pedigrees. J Clin Endocrinol Metab. 2011;96(3):E498\u2013502.","journal-title":"J Clin Endocrinol Metab"},{"issue":"5","key":"9548_CR40","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1002\/humu.22279","volume":"34","author":"K Colclough","year":"2013","unstructured":"Colclough K, Bellanne-Chantelot C, Saint-Martin C, Flanagan SE, Ellard S. Mutations in the genes encoding the transcription factors hepatocyte nuclear factor 1 alpha and 4 alpha in maturity-onset diabetes of the young and hyperinsulinemic hypoglycemia. Hum Mutat. 2013;34(5):669\u201385.","journal-title":"Hum Mutat"},{"issue":"4","key":"9548_CR41","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pmed.0040118","volume":"4","author":"ER Pearson","year":"2007","unstructured":"Pearson ER, Boj SF, Steele AM, Barrett T, Stals K, Shield JP, et al. Macrosomia and hyperinsulinaemic hypoglycaemia in patients with heterozygous mutations in the HNF4A gene. PLoS Med. 2007;4(4):e118.","journal-title":"PLoS Med"},{"issue":"6","key":"9548_CR42","doi-asserted-by":"crossref","first-page":"1659","DOI":"10.2337\/db07-1657","volume":"57","author":"RR Kapoor","year":"2008","unstructured":"Kapoor RR, Locke J, Colclough K, Wales J, Conn JJ, Hattersley AT, et al. Persistent hyperinsulinemic hypoglycemia and maturity-onset diabetes of the young due to heterozygous HNF4A mutations. Diabetes. 2008;57(6):1659\u201363.","journal-title":"Diabetes"},{"issue":"5","key":"9548_CR43","doi-asserted-by":"crossref","first-page":"987","DOI":"10.1530\/EJE-09-0861","volume":"162","author":"SE Flanagan","year":"2010","unstructured":"Flanagan SE, et al. Diazoxide-responsive hyperinsulinemic hypoglycemia caused by HNF4A gene mutations. Eur J Endocrinol. 2010;162(5):987\u201392.","journal-title":"Eur J Endocrinol"},{"issue":"1","key":"9548_CR44","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.1111\/dme.12259","volume":"31","author":"SM McGlacken-Byrne","year":"2014","unstructured":"McGlacken-Byrne SM, et al. The evolving course of HNF4A hyperinsulinaemic hypoglycaemia--a case series. Diabet Med. 2014;31(1):e1\u20135.","journal-title":"Diabet Med"},{"issue":"10","key":"9548_CR45","doi-asserted-by":"crossref","first-page":"E2026","DOI":"10.1210\/jc.2012-1356","volume":"97","author":"DE Stanescu","year":"2012","unstructured":"Stanescu DE, Hughes N, Kaplan B, Stanley CA, de Le\u00f3n DD. Novel presentations of congenital hyperinsulinism due to mutations in the MODY genes: HNF1A and HNF4A. J Clin Endocrinol Metab. 2012;97(10):E2026\u201330.","journal-title":"J Clin Endocrinol Metab"},{"issue":"3","key":"9548_CR46","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1136\/jmedgenet-2013-102066","volume":"51","author":"AJ Hamilton","year":"2014","unstructured":"Hamilton AJ, Bingham C, McDonald T, Cook PR, Caswell RC, Weedon MN, et al. The HNF4A R76W mutation causes atypical dominant Fanconi syndrome in addition to a beta cell phenotype. J Med Genet. 2014;51(3):165\u20139.","journal-title":"J Med Genet"},{"issue":"3","key":"9548_CR47","doi-asserted-by":"crossref","first-page":"e53","DOI":"10.1016\/j.diabres.2015.03.005","volume":"108","author":"C Numakura","year":"2015","unstructured":"Numakura C, Hashimoto Y, Daitsu T, Hayasaka K, Mitsui T, Yorifuji T. Two patients with HNF4A-related congenital hyperinsulinism and renal tubular dysfunction: a clinical variation which includes transient hepatic dysfunction. Diabetes Res Clin Pract. 2015;108(3):e53\u20135.","journal-title":"Diabetes Res Clin Pract"},{"issue":"1","key":"9548_CR48","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1186\/s12882-017-0649-8","volume":"18","author":"SB Walsh","year":"2017","unstructured":"Walsh SB, Unwin R, Kleta R, van't Hoff W, Bass P, Hussain K, et al. Fainting Fanconi syndrome clarified by proxy: a case report. BMC Nephrol. 2017;18(1):230.","journal-title":"BMC Nephrol"},{"issue":"12","key":"9548_CR49","doi-asserted-by":"crossref","first-page":"E1540","DOI":"10.1210\/jc.2015-2763","volume":"100","author":"K Rozenkova","year":"2015","unstructured":"Rozenkova K, Malikova J, Nessa A, Dusatkova L, Bj\u00f8rkhaug L, Obermannova B, et al. High incidence of heterozygous ABCC8 and HNF1A mutations in Czech patients with congenital Hyperinsulinism. J Clin Endocrinol Metab. 2015;100(12):E1540\u20139.","journal-title":"J Clin Endocrinol Metab"},{"issue":"3","key":"9548_CR50","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1136\/adc.84.3.254","volume":"84","author":"T Meissner","year":"2001","unstructured":"Meissner T, Otonkoski T, Feneberg R, Beinbrech B, Apostolidou S, Sipil\u00e4 I, et al. Exercise induced hypoglycaemic hyperinsulinism. Arch Dis Child. 2001;84(3):254\u20137.","journal-title":"Arch Dis Child"},{"issue":"3","key":"9548_CR51","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1086\/520960","volume":"81","author":"T Otonkoski","year":"2007","unstructured":"Otonkoski T, Jiao H, Kaminen-Ahola N, Tapia-Paez I, Ullah MS, Parton LE, et al. Physical exercise-induced hypoglycemia caused by failed silencing of monocarboxylate transporter 1 in pancreatic beta cells. Am J Hum Genet. 2007;81(3):467\u201374.","journal-title":"Am J Hum Genet"},{"issue":"11","key":"9548_CR52","doi-asserted-by":"crossref","first-page":"690","DOI":"10.1055\/s-2005-870583","volume":"37","author":"T Meissner","year":"2005","unstructured":"Meissner T, Friedmann B, Okun JG, Schwab MA, Otonkoski T, Bauer T, et al. Massive insulin secretion in response to anaerobic exercise in exercise-induced hyperinsulinism. Horm Metab Res. 2005;37(11):690\u20134.","journal-title":"Horm Metab Res"},{"issue":"3","key":"9548_CR53","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1038\/ng0397-269","volume":"15","author":"C Fleury","year":"1997","unstructured":"Fleury C, et al. Uncoupling protein-2: a novel gene linked to obesity and hyperinsulinemia. Nat Genet. 1997;15(3):269\u201372.","journal-title":"Nat Genet"},{"issue":"12","key":"9548_CR54","doi-asserted-by":"crossref","first-page":"e3850","DOI":"10.1371\/journal.pone.0003850","volume":"3","author":"MM Gonz\u00e1lez-Barroso","year":"2008","unstructured":"Gonz\u00e1lez-Barroso MM, et al. Mutations in UCP2 in congenital hyperinsulinism reveal a role for regulation of insulin secretion. PLoS One. 2008;3(12):e3850.","journal-title":"PLoS One"},{"issue":"3","key":"9548_CR55","doi-asserted-by":"crossref","first-page":"942","DOI":"10.1210\/jc.2016-3164","volume":"102","author":"CT Ferrara","year":"2017","unstructured":"Ferrara CT, Boodhansingh KE, Paradies E, Fiermonte G, Steinkrauss LJ, Topor LS, et al. Novel hypoglycemia phenotype in congenital Hyperinsulinism due to dominant mutations of uncoupling protein 2. J Clin Endocrinol Metab. 2017;102(3):942\u20139.","journal-title":"J Clin Endocrinol Metab"},{"issue":"10","key":"9548_CR56","doi-asserted-by":"crossref","first-page":"1442","DOI":"10.1002\/humu.23289","volume":"38","author":"TW Laver","year":"2017","unstructured":"Laver TW, Weedon MN, Caswell R, Hussain K, Ellard S, Flanagan SE. Analysis of large-scale sequencing cohorts does not support the role of variants in UCP2 as a cause of hyperinsulinaemic hypoglycaemia. Hum Mutat. 2017;38(10):1442\u20134.","journal-title":"Hum Mutat"},{"issue":"1","key":"9548_CR57","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1159\/000351943","volume":"80","author":"SE Pinney","year":"2013","unstructured":"Pinney SE, Ganapathy K, Bradfield J, Stokes D, Sasson A, Mackiewicz K, et al. Dominant form of congenital hyperinsulinism maps to HK1 region on 10q. Horm Res Paediatr. 2013;80(1):18\u201327.","journal-title":"Horm Res Paediatr"},{"issue":"5","key":"9548_CR58","doi-asserted-by":"crossref","first-page":"1689","DOI":"10.2337\/db12-1414","volume":"62","author":"JC Henquin","year":"2013","unstructured":"Henquin JC, Sempoux C, Marchandise J, Godecharles S, Guiot Y, Nenquin M, et al. Congenital hyperinsulinism caused by hexokinase I expression or glucokinase-activating mutation in a subset of \u03b2-cells. Diabetes. 2013;62(5):1689\u201396.","journal-title":"Diabetes"},{"issue":"6","key":"9548_CR59","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1056\/NEJMoa1206605","volume":"370","author":"LC Tegtmeyer","year":"2014","unstructured":"Tegtmeyer LC, et al. Multiple phenotypes in phosphoglucomutase 1 deficiency. N Engl J Med. 2014;370(6):533\u201342.","journal-title":"N Engl J Med"},{"issue":"8","key":"9548_CR60","doi-asserted-by":"crossref","first-page":"2529","DOI":"10.1681\/ASN.2016121312","volume":"28","author":"OR Cabezas","year":"2017","unstructured":"Cabezas OR, Flanagan SE, Stanescu H, Garc\u00eda-Mart\u00ednez E, Caswell R, Lango-Allen H, et al. Polycystic kidney disease with Hyperinsulinemic hypoglycemia caused by a promoter mutation in Phosphomannomutase 2. J Am Soc Nephrol. 2017;28(8):2529\u201339.","journal-title":"J Am Soc Nephrol"},{"issue":"22","key":"9548_CR61","doi-asserted-by":"crossref","first-page":"4315","DOI":"10.1093\/hmg\/ddx318","volume":"26","author":"D Giri","year":"2017","unstructured":"Giri D, Vignola ML, Gualtieri A, Scagliotti V, McNamara P, Peak M, et al. Novel FOXA2 mutation causes Hyperinsulinism, hypopituitarism with craniofacial and endoderm-derived organ abnormalities. Hum Mol Genet. 2017;26(22):4315\u201326.","journal-title":"Hum Mol Genet"},{"issue":"3","key":"9548_CR62","doi-asserted-by":"crossref","first-page":"1042","DOI":"10.1210\/jc.2017-02157","volume":"103","author":"ME Vajravelu","year":"2018","unstructured":"Vajravelu ME, et al. Congenital Hyperinsulinism and hypopituitarism attributable to a mutation in FOXA2. J Clin Endocrinol Metab. 2018;103(3):1042\u20137.","journal-title":"J Clin Endocrinol Metab"},{"issue":"4","key":"9548_CR63","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1111\/pedi.12512","volume":"18","author":"SE Flanagan","year":"2017","unstructured":"Flanagan SE, Vairo F, Johnson MB, Caswell R, Laver TW, Lango Allen H, et al. A CACNA1D mutation in a patient with persistent hyperinsulinaemic hypoglycaemia, heart defects, and severe hypotonia. Pediatr Diabetes. 2017;18(4):320\u20133.","journal-title":"Pediatr Diabetes"},{"key":"9548_CR64","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1016\/j.ebiom.2019.03.013","volume":"42","author":"LC Gregory","year":"2019","unstructured":"Gregory LC, Ferreira CB, Young-Baird SK, Williams HJ, Harakalova M, van Haaften G, et al. Impaired EIF2S3 function associated with a novel phenotype of X-linked hypopituitarism with glucose dysregulation. EBioMedicine. 2019;42:470\u201380.","journal-title":"EBioMedicine"},{"issue":"5\u20136","key":"9548_CR65","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1007\/s003830000525","volume":"17","author":"P Bufler","year":"2001","unstructured":"Bufler P, Ehringhaus C, Koletzko S. Dumping syndrome: a common problem following Nissen fundoplication in young children. Pediatr Surg Int. 2001;17(5\u20136):351\u20135.","journal-title":"Pediatr Surg Int"},{"issue":"2","key":"9548_CR66","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1097\/MED.0b013e32834449b9","volume":"18","author":"KE Foster-Schubert","year":"2011","unstructured":"Foster-Schubert KE. Hypoglycemia complicating bariatric surgery: incidence and mechanisms. Curr Opin Endocrinol Diabetes Obes. 2011;18(2):129\u201333.","journal-title":"Curr Opin Endocrinol Diabetes Obes"},{"issue":"1","key":"9548_CR67","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1210\/jc.2008-1263","volume":"94","author":"AA Palladino","year":"2009","unstructured":"Palladino AA, et al. Increased glucagon-like peptide-1 secretion and postprandial hypoglycemia in children after Nissen fundoplication. J Clin Endocrinol Metab. 2009;94(1):39\u201344.","journal-title":"J Clin Endocrinol Metab"},{"issue":"7","key":"9548_CR68","first-page":"2227","volume":"31","author":"Y Hirata","year":"1973","unstructured":"Hirata Y. Insulin autoimmune syndrome. Nihon Rinsho. 1973;31(7):2227\u201331.","journal-title":"Nihon Rinsho"},{"issue":"2","key":"9548_CR69","doi-asserted-by":"crossref","first-page":"229","DOI":"10.2217\/fon.09.165","volume":"6","author":"JJ Shin","year":"2010","unstructured":"Shin JJ, Gorden P, Libutti SK. Insulinoma: pathophysiology, localization and management. Future Oncol. 2010;6(2):229\u201337.","journal-title":"Future Oncol"},{"issue":"7","key":"9548_CR70","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1515\/JPEM.2010.23.7.719","volume":"23","author":"A Ozon","year":"2010","unstructured":"Ozon A, Demirbilek H, Ertugrul A, Unal S, Gumruk F, Kandemir N. Anemia and neutropenic fever with high dose diazoxide treatment in a case with hyperinsulinism due to Munchausen by proxy. J Pediatr Endocrinol Metab. 2010;23(7):719\u201323.","journal-title":"J Pediatr Endocrinol Metab"},{"issue":"2","key":"9548_CR71","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1002\/ajmg.a.38011","volume":"173","author":"N Toda","year":"2017","unstructured":"Toda N, Ihara K, Kojima-Ishii K, Ochiai M, Ohkubo K, Kawamoto Y, et al. Hyperinsulinemic hypoglycemia in Beckwith-Wiedemann, Sotos, and kabuki syndromes: a nationwide survey in Japan. Am J Med Genet A. 2017;173(2):360\u20137.","journal-title":"Am J Med Genet A"},{"issue":"10","key":"9548_CR72","doi-asserted-by":"crossref","first-page":"3932","DOI":"10.1172\/JCI58400","volume":"121","author":"JC Henquin","year":"2011","unstructured":"Henquin JC, Nenquin M, Sempoux C, Guiot Y, Bellann\u00e9-Chantelot C, Otonkoski T, et al. In vitro insulin secretion by pancreatic tissue from infants with diazoxide-resistant congenital hyperinsulinism deviates from model predictions. J Clin Invest. 2011;121(10):3932\u201342.","journal-title":"J Clin Invest"},{"issue":"12","key":"9548_CR73","doi-asserted-by":"crossref","first-page":"3785","DOI":"10.1210\/jc.2010-3032","volume":"96","author":"C Sempoux","year":"2011","unstructured":"Sempoux C, et al. Morphological Mosaicism of the pancreatic islets: a novel Anatomopathological form of persistent Hyperinsulinemic hypoglycemia of infancy. J Clin Endocrinol Metab. 2011;96(12):3785\u201393.","journal-title":"J Clin Endocrinol Metab"},{"issue":"12","key":"9548_CR74","doi-asserted-by":"crossref","first-page":"4941","DOI":"10.1210\/jc.2008-0673","volume":"93","author":"L Damaj","year":"2008","unstructured":"Damaj L, le Lorch M, Verkarre V, Werl C, Hubert L, Nihoul-F\u00e9k\u00e9t\u00e9 C, et al. Chromosome 11p15 paternal isodisomy in focal forms of neonatal hyperinsulinism. J Clin Endocrinol Metab. 2008;93(12):4941\u20137.","journal-title":"J Clin Endocrinol Metab"},{"issue":"4","key":"9548_CR75","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1007\/BF00283651","volume":"26","author":"J Rahier","year":"1984","unstructured":"Rahier J, F\u00e4lt K, M\u00fcntefering H, Becker K, Gepts W, Falkmer S. The basic structural lesion of persistent neonatal hypoglycaemia with hyperinsulinism: deficiency of pancreatic D cells or hyperactivity of B cells? Diabetologia. 1984;26(4):282\u20139.","journal-title":"Diabetologia"},{"issue":"2","key":"9548_CR76","doi-asserted-by":"crossref","first-page":"F108","DOI":"10.1136\/fn.82.2.F108","volume":"82","author":"J Rahier","year":"2000","unstructured":"Rahier J, Guiot Y, Sempoux C. Persistent hyperinsulinaemic hypoglycaemia of infancy: a heterogeneous syndrome unrelated to nesidioblastosis. Arch Dis Child Fetal Neonatal Ed. 2000;82(2):F108\u201312.","journal-title":"Arch Dis Child Fetal Neonatal Ed"},{"issue":"9","key":"9548_CR77","doi-asserted-by":"crossref","first-page":"766","DOI":"10.1097\/00000478-198909000-00006","volume":"3","author":"AGW Goossens","year":"1989","unstructured":"Goossens AGW. Saudubray JM, Bonnefont JP, Nihoul-Fekete, Heitz PU, Kl\u00f6ppel G., diffuse and focal nesidioblastosis. A clinicopathological study of 24 patients with persistent neonatal hyperinsulinemic hypoglycemia. Am J Surg Pathol. 1989;3(9):766\u201355.","journal-title":"Am J Surg Pathol"},{"issue":"5","key":"9548_CR78","first-page":"1455","volume":"83","author":"C Sempoux","year":"1998","unstructured":"Sempoux C, et al. Neonatal hyperinsulinemic hypoglycemia: heterogeneity of the syndrome and keys for differential diagnosis. J Clin Endocrinol Metab. 1998;83(5):1455\u201361.","journal-title":"J Clin Endocrinol Metab"},{"issue":"1","key":"9548_CR79","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1046\/j.1365-2559.1998.00326.x","volume":"32","author":"J Rahier","year":"1998","unstructured":"Rahier J, et al. Partial or near-total pancreatectomy for persistent neonatal hyperinsulinaemic hypoglycaemia: the pathologist's role. Histopathology. 1998;32(1):15\u20139.","journal-title":"Histopathology"},{"issue":"1","key":"9548_CR80","doi-asserted-by":"crossref","first-page":"13","DOI":"10.2337\/diabetes.55.01.06.db05-1128","volume":"55","author":"T Otonkoski","year":"2006","unstructured":"Otonkoski T, et al. Noninvasive diagnosis of focal Hyperinsulinism of infancy with [18F]-DOPA positron emission tomography. Diabetes. 2006;55(1):13\u20138.","journal-title":"Diabetes"},{"issue":"3","key":"9548_CR81","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1385\/EP:15:3:241","volume":"15","author":"C Sempoux","year":"2004","unstructured":"Sempoux C, Guiot Y, Jaubert F, Rahier J. Focal and diffuse forms of congenital hyperinsulinism: the keys for differential diagnosis. Endocr Pathol. 2004;15(3):241\u20136.","journal-title":"Endocr Pathol"},{"issue":"1","key":"9548_CR82","doi-asserted-by":"crossref","first-page":"259","DOI":"10.2337\/db07-0998","volume":"57","author":"K Hussain","year":"2008","unstructured":"Hussain K, et al. An ABCC8 gene mutation and mosaic uniparental isodisomy resulting in atypical diffuse congenital hyperinsulinism. Diabetes. 2008;57(1):259\u201363.","journal-title":"Diabetes"},{"issue":"5","key":"9548_CR83","doi-asserted-by":"crossref","first-page":"1689","DOI":"10.2337\/db12-1414","volume":"62","author":"JC Henquin","year":"2013","unstructured":"Henquin JC, Sempoux C, Marchandise J, Godecharles S, Guiot Y, Nenquin M, et al. Congenital hyperinsulinism caused by hexokinase I expression or glucokinase-activating mutation in a subset of beta-cells. Diabetes. 2013;62(5):1689\u201396.","journal-title":"Diabetes"},{"issue":"1","key":"9548_CR84","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/j.jpeds.2014.09.019","volume":"166","author":"Y Shi","year":"2015","unstructured":"Shi Y, Avatapalle HB, Skae MS, Padidela R, Newbould M, Rigby L, et al. Increased plasma Incretin concentrations identifies a subset of patients with persistent congenital Hyperinsulinism without KATP Channel gene defects. J Pediatr. 2015;166(1):191\u20134.","journal-title":"J Pediatr"},{"issue":"7","key":"9548_CR85","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1016\/j.clinbiochem.2011.03.016","volume":"44","author":"K Hussain","year":"2011","unstructured":"Hussain K. Investigations for neonatal hypoglycaemia. Clin Biochem. 2011;44(7):465\u20136.","journal-title":"Clin Biochem"},{"issue":"2","key":"9548_CR86","doi-asserted-by":"crossref","first-page":"F98","DOI":"10.1136\/fn.82.2.F98","volume":"82","author":"A Aynsley-Green","year":"2000","unstructured":"Aynsley-Green A, Hussain K, Hall J, Saudubray JM, Nihoul-F\u00e9k\u00e9t\u00e9 C, de Lonlay-Debeney P, et al. Practical management of hyperinsulinism in infancy. Arch Dis Child Fetal Neonatal Ed. 2000;82(2):F98\u2013F107.","journal-title":"Arch Dis Child Fetal Neonatal Ed"},{"issue":"3","key":"9548_CR87","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1297\/cpe.26.127","volume":"26","author":"T Yorifuji","year":"2017","unstructured":"Yorifuji T, Horikawa R, Hasegawa T, Adachi M, Soneda S, Minagawa M, et al. Clinical practice guidelines for congenital hyperinsulinism. Clin Pediatr Endocrinol. 2017;26(3):127\u201352.","journal-title":"Clin Pediatr Endocrinol"},{"issue":"2","key":"9548_CR88","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1373\/clinchem.2007.098988","volume":"54","author":"AA Palladino","year":"2008","unstructured":"Palladino AA, Bennett MJ, Stanley CA. Hyperinsulinism in infancy and childhood: when an insulin level is not always enough. Clin Chem. 2008;54(2):256\u201363.","journal-title":"Clin Chem"},{"issue":"11","key":"9548_CR89","doi-asserted-by":"crossref","first-page":"1435","DOI":"10.1007\/s00431-013-2053-0","volume":"172","author":"H Al-Otaibi","year":"2013","unstructured":"Al-Otaibi H, et al. Biochemical studies in patients with hyperinsulinaemic hypoglycaemia. Eur J Pediatr. 2013;172(11):1435\u201340.","journal-title":"Eur J Pediatr"},{"key":"9548_CR90","doi-asserted-by":"crossref","unstructured":"Ferrara C, et al. Biomarkers of insulin for the diagnosis of Hyperinsulinemic hypoglycemia in infants and children. J Pediatr. 2016;168:212\u20139.","DOI":"10.1016\/j.jpeds.2015.09.045"},{"issue":"4","key":"9548_CR91","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1007\/BF00410289","volume":"38","author":"JF Brun","year":"1995","unstructured":"Brun JF, F\u00e9dou C, Bouix O, Raynaud E, Orsetti A. Evaluation of a standardized hyperglucidic breakfast test in postprandial reactive hypoglycaemia. Diabetologia. 1995;38(4):494\u2013501.","journal-title":"Diabetologia"},{"issue":"1","key":"9548_CR92","doi-asserted-by":"crossref","first-page":"199","DOI":"10.2337\/diabetes.52.1.199","volume":"52","author":"T Otonkoski","year":"2003","unstructured":"Otonkoski T, Kaminen N, Ustinov J, Lapatto R, Meissner T, Mayatepek E, et al. Physical exercise-induced hyperinsulinemic hypoglycemia is an autosomal-dominant trait characterized by abnormal pyruvate-induced insulin release. Diabetes. 2003;52(1):199\u2013204.","journal-title":"Diabetes"},{"key":"9548_CR93","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1186\/s13633-018-0057-2","volume":"2018","author":"H Alsaffar","year":"2018","unstructured":"Alsaffar H, et al. Continuous flash glucose monitoring in children with congenital Hyperinsulinism; first report on accuracy and patient experience. Int J Pediatr Endocrinol. 2018;2018:3.","journal-title":"Int J Pediatr Endocrinol"},{"issue":"6","key":"9548_CR94","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1097\/MNM.0b013e32836069d0","volume":"34","author":"M Meintjes","year":"2013","unstructured":"Meintjes M, Endozo R, Dickson J, Erlandsson K, Hussain K, Townsend C, et al. 18F-DOPA PET and enhanced CT imaging for congenital hyperinsulinism: initial UK experience from a technologist's perspective. Nucl Med Commun. 2013;34(6):601\u20138.","journal-title":"Nucl Med Commun"},{"issue":"11","key":"9548_CR95","doi-asserted-by":"crossref","first-page":"E1786","DOI":"10.1210\/jc.2013-2094","volume":"98","author":"K Lord","year":"2013","unstructured":"Lord K, et al. Clinical presentation and management of children with diffuse and focal hyperinsulinism: a review of 223 cases. J Clin Endocrinol Metab. 2013;98(11):E1786\u20139.","journal-title":"J Clin Endocrinol Metab"},{"issue":"1","key":"9548_CR96","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1007\/s11307-012-0572-0","volume":"15","author":"BA Blomberg","year":"2013","unstructured":"Blomberg BA, et al. The value of radiologic interventions and (18)F-DOPA PET in diagnosing and localizing focal congenital hyperinsulinism: systematic review and meta-analysis. Mol Imaging Biol. 2013;15(1):97\u2013105.","journal-title":"Mol Imaging Biol"},{"issue":"1","key":"9548_CR97","doi-asserted-by":"crossref","first-page":"E94","DOI":"10.1210\/jc.2011-1628","volume":"97","author":"D Ismail","year":"2012","unstructured":"Ismail D, Kapoor RR, Smith VV, Ashworth M, Blankenstein O, Pierro A, et al. The heterogeneity of focal forms of congenital hyperinsulinism. J Clin Endocrinol Metab. 2012;97(1):E94\u20139.","journal-title":"J Clin Endocrinol Metab"},{"issue":"12","key":"9548_CR98","doi-asserted-by":"crossref","first-page":"4706","DOI":"10.1210\/jc.2007-1637","volume":"92","author":"OT Hardy","year":"2007","unstructured":"Hardy OT, et al. Accuracy of [18F]fluorodopa positron emission tomography for diagnosing and localizing focal congenital hyperinsulinism. J Clin Endocrinol Metab. 2007;92(12):4706\u201311.","journal-title":"J Clin Endocrinol Metab"},{"issue":"6","key":"9548_CR99","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1111\/cen.12153","volume":"78","author":"I Banerjee","year":"2013","unstructured":"Banerjee I, Avatapalle B, Padidela R, Stevens A, Cosgrove KE, Clayton PE, et al. Integrating genetic and imaging investigations into the clinical management of congenital hyperinsulinism. Clin Endocrinol. 2013;78(6):803\u201313.","journal-title":"Clin Endocrinol"},{"key":"9548_CR100","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1159\/000109605","volume":"12","author":"MJ Ribeiro","year":"2007","unstructured":"Ribeiro MJ, Boddaert N, Delzescaux T, Valayannopoulos V, Bellann\u00e9-Chantelot C, Jaubert F, et al. Functional imaging of the pancreas: the role of [18F]fluoro-L-DOPA PET in the diagnosis of hyperinsulinism of infancy. Endocr Dev. 2007;12:55\u201366.","journal-title":"Endocr Dev"},{"issue":"3","key":"9548_CR101","doi-asserted-by":"crossref","first-page":"869","DOI":"10.1210\/jc.2007-2036","volume":"93","author":"W Barthlen","year":"2008","unstructured":"Barthlen W, et al. Evaluation of [18F]fluoro-L-DOPA positron emission tomography-computed tomography for surgery in focal congenital hyperinsulinism. J Clin Endocrinol Metab. 2008;93(3):869\u201375.","journal-title":"J Clin Endocrinol Metab"},{"issue":"1","key":"9548_CR102","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1016\/j.jpedsurg.2010.09.093","volume":"46","author":"A Zani","year":"2011","unstructured":"Zani A, et al. The predictive value of preoperative fluorine-18-L-3,4-dihydroxyphenylalanine positron emission tomography-computed tomography scans in children with congenital hyperinsulinism of infancy. J Pediatr Surg. 2011;46(1):204\u20138.","journal-title":"J Pediatr Surg"},{"issue":"1","key":"9548_CR103","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1148\/radiol.2532081445","volume":"253","author":"C Capito","year":"2009","unstructured":"Capito C, Khen-Dunlop N, Ribeiro MJ, Brunelle F, Aigrain Y, Cr\u00e9tolle C, et al. Value of 18F-fluoro-L-dopa PET in the preoperative localization of focal lesions in congenital hyperinsulinism. Radiology. 2009;253(1):216\u201322.","journal-title":"Radiology"},{"issue":"11","key":"9548_CR104","doi-asserted-by":"crossref","first-page":"1372","DOI":"10.1007\/s00247-012-2459-2","volume":"42","author":"G Treglia","year":"2012","unstructured":"Treglia G, Mirk P, Giordano A, Rufini V. Diagnostic performance of fluorine-18-dihydroxyphenylalanine positron emission tomography in diagnosing and localizing the focal form of congenital hyperinsulinism: a meta-analysis. Pediatr Radiol. 2012;42(11):1372\u20139.","journal-title":"Pediatr Radiol"},{"issue":"11","key":"9548_CR105","doi-asserted-by":"crossref","first-page":"e0186340","DOI":"10.1371\/journal.pone.0186340","volume":"12","author":"PK Garg","year":"2017","unstructured":"Garg PK, et al. Pancreatic uptake and radiation dosimetry of 6-[18F]fluoro-L-DOPA from PET imaging studies in infants with congenital hyperinsulinism. PLoS One. 2017;12(11):e0186340.","journal-title":"PLoS One"},{"issue":"4","key":"9548_CR106","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1007\/s13139-016-0434-9","volume":"51","author":"E Maines","year":"2017","unstructured":"Maines E, Giacomello L, D'Onofrio M, Salgarello M, Gaudino R, Baggio L, et al. Images from. Nucl Med Mol Imaging. 2017;51(4):362\u20133.","journal-title":"Nucl Med Mol Imaging"},{"issue":"6","key":"9548_CR107","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1111\/cen.12473","volume":"81","author":"P K\u00fchnen","year":"2014","unstructured":"K\u00fchnen P, Matthae R, Arya V, Hauptmann K, Rothe K, W\u00e4chter S, et al. Occurrence of giant focal forms of congenital hyperinsulinism with incorrect visualization by (18) F DOPA-PET\/CT scanning. Clin Endocrinol. 2014;81(6):847\u201354.","journal-title":"Clin Endocrinol"},{"key":"9548_CR108","doi-asserted-by":"crossref","unstructured":"Parihar AS, et  al. 68Ga DOTA-Exendin PET\/CT for detection of Insulinoma in a patient with persistent Hyperinsulinemic hypoglycemia. Clin Nucl Med. 2018;43(8):e285\u2013e286.","DOI":"10.1097\/RLU.0000000000002155"},{"issue":"5","key":"9548_CR109","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1111\/cen.12973","volume":"84","author":"DJ Cuthbertson","year":"2016","unstructured":"Cuthbertson DJ, Banks M, Khoo B, Antwi K, Christ E, Campbell F, et al. Application of Ga(68) -DOTA-exendin-4 PET\/CT to localize an occult insulinoma. Clin Endocrinol. 2016;84(5):789\u201391.","journal-title":"Clin Endocrinol"},{"issue":"3","key":"9548_CR110","doi-asserted-by":"crossref","first-page":"198","DOI":"10.2967\/jnmt.117.192708","volume":"45","author":"SA Tuzcu","year":"2017","unstructured":"Tuzcu SA, Pekkolay Z, K\u0131l\u0131n\u00e7 F, Tuzcu AK. Ga-DOTATATE PET\/CT can be an alternative imaging method in Insulinoma patients. J Nucl Med Technol. 2017;45(3):198\u2013200.","journal-title":"J Nucl Med Technol"},{"issue":"6","key":"9548_CR111","doi-asserted-by":"crossref","first-page":"872","DOI":"10.2967\/jnumed.115.165803","volume":"57","author":"SA Deppen","year":"2016","unstructured":"Deppen SA, Blume J, Bobbey AJ, Shah C, Graham MM, Lee P, et al. 68Ga-DOTATATE compared with 111In-DTPA-Octreotide and conventional imaging for pulmonary and Gastroenteropancreatic neuroendocrine tumors: a systematic review and meta-analysis. J Nucl Med. 2016;57(6):872\u20138.","journal-title":"J Nucl Med"},{"issue":"1","key":"9548_CR112","first-page":"69","volume":"60","author":"P Sharma","year":"2016","unstructured":"Sharma P, et al. Somatostatin receptor based PET\/CT imaging with 68Ga-DOTA-Nal3-octreotide for localization of clinically and biochemically suspected insulinoma. Q J Nucl Med Mol Imaging. 2016;60(1):69\u201376.","journal-title":"Q J Nucl Med Mol Imaging"},{"issue":"7","key":"9548_CR113","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1136\/adc.2006.115543","volume":"92","author":"K Hussain","year":"2007","unstructured":"Hussain K, Blankenstein O, de Lonlay P, Christesen HT. Hyperinsulinaemic hypoglycaemia: biochemical basis and the importance of maintaining normoglycaemia during management. Arch Dis Child. 2007;92(7):568\u201370.","journal-title":"Arch Dis Child"},{"key":"9548_CR114","doi-asserted-by":"crossref","unstructured":"Nebesio TD, Hoover WC, Caldwell RL, Nitu ME, Eugster EA. Development of pulmonary hypertension in an infant treated with diazoxide. J Pediatr Endocrinol Metab. 2007;20(8):939\u201344.","DOI":"10.1515\/JPEM.2007.20.8.939"},{"key":"9548_CR115","doi-asserted-by":"crossref","unstructured":"Timlin MR, Black AB, Delaney HM, Matos RI, Percival CS. Development of pulmonary hypertension during treatment with Diazoxide: a case series and literature review. Pediatr Cardiol. 2017;38(6):1247\u201350.","DOI":"10.1007\/s00246-017-1652-3"},{"key":"9548_CR116","doi-asserted-by":"crossref","unstructured":"Chen SC, Dastamani A, Pintus D, Yau D, Aftab S, Bath L, et al. Diazoxide\u2010induced pulmonary hypertension in hyperinsulinaemic hypoglycaemia: Recommendations from a multicentre study in the United Kingdom. Clin Endocrinol. 2019;91(6):770\u2013775.","DOI":"10.1111\/cen.14096"},{"key":"9548_CR117","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1186\/1750-1172-6-63","volume":"6","author":"JB Arnoux","year":"2011","unstructured":"Arnoux JB, et al. Congenital hyperinsulinism: current trends in diagnosis and therapy. Orphanet J Rare Dis. 2011;6:63.","journal-title":"Orphanet J Rare Dis"},{"issue":"1","key":"9548_CR118","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1136\/fn.89.1.F83","volume":"89","author":"D M\u00fcller","year":"2004","unstructured":"M\u00fcller D, Zimmering M, Roehr CC. Should nifedipine be used to counter low blood sugar levels in children with persistent hyperinsulinaemic hypoglycaemia? Arch Dis Child. 2004;89(1):83\u20135.","journal-title":"Arch Dis Child"},{"issue":"6","key":"9548_CR119","first-page":"873","volume":"12","author":"F Ba\u015f","year":"1999","unstructured":"Ba\u015f F, et al. Successful therapy with calcium channel blocker (nifedipine) in persistent neonatal hyperinsulinemic hypoglycemia of infancy. J Pediatr Endocrinol Metab. 1999;12(6):873\u20138.","journal-title":"J Pediatr Endocrinol Metab"},{"issue":"3","key":"9548_CR120","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1007\/BF02734240","volume":"69","author":"P Shanbag","year":"2002","unstructured":"Shanbag P, Pathak A, Vaidya M, Shahid SK. Persistent hyperinsulinemic hypoglycemia of infancy--successful therapy with nifedipine. Indian J Pediatr. 2002;69(3):271\u20132.","journal-title":"Indian J Pediatr"},{"issue":"3","key":"9548_CR121","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1007\/s004310051049","volume":"158","author":"D Eichmann","year":"1999","unstructured":"Eichmann D, Hufnagel M, Quick P, Santer R. Treatment of hyperinsulinaemic hypoglycaemia with nifedipine. Eur J Pediatr. 1999;158(3):204\u20136.","journal-title":"Eur J Pediatr"},{"key":"9548_CR122","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1186\/s13023-015-0367-x","volume":"10","author":"A Welters","year":"2015","unstructured":"Welters A, et al. Long-term medical treatment in congenital hyperinsulinism: a descriptive analysis in a large cohort of patients from different clinical centers. Orphanet J Rare Dis. 2015;10:150.","journal-title":"Orphanet J Rare Dis"},{"issue":"3","key":"9548_CR123","first-page":"822","volume":"102","author":"M G\u00fcemes","year":"2017","unstructured":"G\u00fcemes M, Shah P, Silvera S, Morgan K, Gilbert C, Hinchey L, et al. Assessment of Nifedipine therapy in Hyperinsulinemic hypoglycemia due to mutations in the ABCC8 gene. J Clin Endocrinol Metab. 2017;102(3):822\u201330.","journal-title":"J Clin Endocrinol Metab"},{"issue":"2","key":"9548_CR124","doi-asserted-by":"crossref","first-page":"119","DOI":"10.4274\/jcrpe.1230","volume":"6","author":"E Durmaz","year":"2014","unstructured":"Durmaz E, Flanagan SE, Parlak M, Ellard S, Akcurin S, Bircan I. A combination of nifedipine and octreotide treatment in an hyperinsulinemic hypoglycemic infant. J Clin Res Pediatr Endocrinol. 2014;6(2):119\u201321.","journal-title":"J Clin Res Pediatr Endocrinol"},{"issue":"4","key":"9548_CR125","doi-asserted-by":"crossref","first-page":"644","DOI":"10.1016\/S0022-3476(05)80970-9","volume":"123","author":"B Glaser","year":"1993","unstructured":"Glaser B, Hirsch HJ, Landau H. Persistent hyperinsulinemic hypoglycemia of infancy: long-term octreotide treatment without pancreatectomy. J Pediatr. 1993;123(4):644\u201350.","journal-title":"J Pediatr"},{"issue":"4","key":"9548_CR126","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1016\/S0022-3476(05)80969-2","volume":"123","author":"PS Thornton","year":"1993","unstructured":"Thornton PS, Alter CA, Katz LE, Baker L, Stanley CA. Short- and long-term use of octreotide in the treatment of congenital hyperinsulinism. J Pediatr. 1993;123(4):637\u201343.","journal-title":"J Pediatr"},{"issue":"2","key":"9548_CR127","doi-asserted-by":"crossref","first-page":"86","DOI":"10.4274\/jcrpe.1891","volume":"7","author":"K Ro\u017eenkov\u00e1","year":"2015","unstructured":"Ro\u017eenkov\u00e1 K, et al. The diagnosis and Management of Hyperinsulinaemic Hypoglycaemia. J Clin Res Pediatr Endocrinol. 2015;7(2):86\u201397.","journal-title":"J Clin Res Pediatr Endocrinol"},{"issue":"1","key":"9548_CR128","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1159\/000129680","volume":"70","author":"K Mohnike","year":"2008","unstructured":"Mohnike K, Blankenstein O, Pfuetzner A, P\u00f6tzsch S, Schober E, Steiner S, et al. Long-term non-surgical therapy of severe persistent congenital hyperinsulinism with glucagon. Horm Res. 2008;70(1):59\u201364.","journal-title":"Horm Res"},{"issue":"5","key":"9548_CR129","first-page":"337","volume":"26","author":"JF Brun","year":"2000","unstructured":"Brun JF, Fedou C, Mercier J. Postprandial reactive hypoglycemia. Diabetes Metab. 2000;26(5):337\u201351.","journal-title":"Diabetes Metab"},{"issue":"2","key":"9548_CR130","doi-asserted-by":"crossref","first-page":"94","DOI":"10.2165\/00003088-199630020-00002","volume":"30","author":"T Salvatore","year":"1996","unstructured":"Salvatore T, Giugliano D. Pharmacokinetic-pharmacodynamic relationships of Acarbose. Clin Pharmacokinet. 1996;30(2):94\u2013106.","journal-title":"Clin Pharmacokinet"},{"issue":"2","key":"9548_CR131","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1530\/EJE-11-0874","volume":"166","author":"KH Le Quan Sang","year":"2012","unstructured":"Le Quan Sang KH, et al. Successful treatment of congenital hyperinsulinism with long-acting release octreotide. Eur J Endocrinol. 2012;166(2):333\u20139.","journal-title":"Eur J Endocrinol"},{"issue":"8","key":"9548_CR132","doi-asserted-by":"crossref","first-page":"2312","DOI":"10.1210\/jc.2011-0605","volume":"96","author":"D Modan-Moses","year":"2011","unstructured":"Modan-Moses D, Koren I, Mazor-Aronovitch K, Pinhas-Hamiel O, Landau H. Treatment of congenital hyperinsulinism with lanreotide acetate (Somatuline autogel). J Clin Endocrinol Metab. 2011;96(8):2312\u20137.","journal-title":"J Clin Endocrinol Metab"},{"issue":"5","key":"9548_CR133","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1159\/000439131","volume":"84","author":"P Shah","year":"2015","unstructured":"Shah P, Rahman SA, McElroy S, Gilbert C, Morgan K, Hinchey L, et al. Use of long-acting Somatostatin analogue (Lanreotide) in an adolescent with Diazoxide-responsive congenital Hyperinsulinism and its psychological impact. Horm Res Paediatr. 2015;84(5):355\u201360.","journal-title":"Horm Res Paediatr"},{"issue":"2","key":"9548_CR134","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1159\/000341525","volume":"78","author":"P K\u00fchnen","year":"2012","unstructured":"K\u00fchnen P, et al. Long-term lanreotide treatment in six patients with congenital hyperinsulinism. Horm Res Paediatr. 2012;78(2):106\u201312.","journal-title":"Horm Res Paediatr"},{"issue":"2","key":"9548_CR135","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1159\/000485184","volume":"89","author":"I van der Steen","year":"2018","unstructured":"van der Steen I, van Albada M, Mohnike K, Christesen HT, Empting S, Salomon-Estebanez M, et al. A multicenter experience with long-acting Somatostatin analogues in patients with congenital Hyperinsulinism. Horm Res Paediatr. 2018;89(2):82\u20139.","journal-title":"Horm Res Paediatr"},{"issue":"1","key":"9548_CR136","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1186\/s13023-017-0653-x","volume":"12","author":"H Corda","year":"2017","unstructured":"Corda H, et al. Treatment with long-acting lanreotide autogel in early infancy in patients with severe neonatal hyperinsulinism. Orphanet J Rare Dis. 2017;12(1):108.","journal-title":"Orphanet J Rare Dis"},{"issue":"1","key":"9548_CR137","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1159\/000491101","volume":"91","author":"A Dastamani","year":"2019","unstructured":"Dastamani A, G\u00fcemes M, Pitfield C, Morgan K, Rajab M, Rottenburger C, et al. The use of a long-acting Somatostatin analogue (Lanreotide) in three children with focal forms of congenital Hyperinsulinaemic Hypoglycaemia. Horm Res Paediatr. 2019;91(1):56\u201361.","journal-title":"Horm Res Paediatr"},{"issue":"2","key":"9548_CR138","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1056\/NEJMc0806740","volume":"360","author":"MH Kulke","year":"2009","unstructured":"Kulke MH, Bergsland EK, Yao JC. Glycemic control in patients with insulinoma treated with everolimus. N Engl J Med. 2009;360(2):195\u20137.","journal-title":"N Engl J Med"},{"issue":"7","key":"9548_CR139","first-page":"691","volume":"3","author":"S Alexandrescu","year":"2010","unstructured":"Alexandrescu S, et al. Persistent hyperinsulinemic hypoglycemia of infancy: constitutive activation of the mTOR pathway with associated exocrine-islet transdifferentiation and therapeutic implications. Int J Clin Exp Pathol. 2010;3(7):691\u2013705.","journal-title":"Int J Clin Exp Pathol"},{"issue":"12","key":"9548_CR140","doi-asserted-by":"crossref","first-page":"1131","DOI":"10.1056\/NEJMoa1310967","volume":"370","author":"S Senniappan","year":"2014","unstructured":"Senniappan S, Alexandrescu S, Tatevian N, Shah P, Arya V, Flanagan S, et al. Sirolimus therapy in infants with severe hyperinsulinemic hypoglycemia. N Engl J Med. 2014;370(12):1131\u20137.","journal-title":"N Engl J Med"},{"issue":"5","key":"9548_CR141","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1159\/000443398","volume":"85","author":"M Guemes","year":"2016","unstructured":"Guemes M, et al. Severe Hyperinsulinaemic Hypoglycaemia in Beckwith-Wiedemann syndrome due to paternal Uniparental Disomy of 11p15.5 managed with Sirolimus therapy. Horm Res Paediatr. 2016;85(5):353\u20137.","journal-title":"Horm Res Paediatr"},{"issue":"5\u20136","key":"9548_CR142","first-page":"695","volume":"28","author":"P Shah","year":"2015","unstructured":"Shah P, Arya VB, Flanagan SE, Morgan K, Ellard S, Senniappan S, et al. Sirolimus therapy in a patient with severe hyperinsulinaemic hypoglycaemia due to a compound heterozygous ABCC8 gene mutation. J Pediatr Endocrinol Metab. 2015;28(5\u20136):695\u20139.","journal-title":"J Pediatr Endocrinol Metab"},{"issue":"9","key":"9548_CR143","doi-asserted-by":"crossref","first-page":"1013","DOI":"10.1515\/jpem-2016-0229","volume":"30","author":"R Al-Balwi","year":"2017","unstructured":"Al-Balwi R, et al. Sirolimus in the treatment of three infants with diffuse congenital hyperinsulinism. J Pediatr Endocrinol Metab. 2017;30(9):1013\u20137.","journal-title":"J Pediatr Endocrinol Metab"},{"issue":"5","key":"9548_CR144","doi-asserted-by":"crossref","first-page":"e1373","DOI":"10.1542\/peds.2015-1132","volume":"136","author":"M Minute","year":"2015","unstructured":"Minute M, et al. Sirolimus therapy in congenital Hyperinsulinism: a successful experience beyond infancy. Pediatrics. 2015;136(5):e1373\u20136.","journal-title":"Pediatrics"},{"issue":"5","key":"9548_CR145","doi-asserted-by":"crossref","first-page":"e1369","DOI":"10.1542\/peds.2014-4200","volume":"136","author":"\u00dc M\u00e9der","year":"2015","unstructured":"M\u00e9der \u00dc, et al. Severe Hyperinsulinemic hypoglycemia in a neonate: response to Sirolimus therapy. Pediatrics. 2015;136(5):e1369\u201372.","journal-title":"Pediatrics"},{"key":"9548_CR146","doi-asserted-by":"crossref","unstructured":"Halilo\u011flu B, T\u00fcz\u00fcn H, Flanagan SE, et  al. Sirolimus-Induced hepatitis in two patients with hyperinsulinemic hypoglycemia. J Clin Res Pediatr Endocrinol. 2018;10(3):279\u2013283.","DOI":"10.4274\/jcrpe.5335"},{"issue":"11","key":"9548_CR147","doi-asserted-by":"crossref","first-page":"1219","DOI":"10.1515\/jpem-2017-0148","volume":"30","author":"A Dastamani","year":"2017","unstructured":"Dastamani A, G\u00fcemes M, Walker J, Shah P, Hussain K. Sirolimus precipitating diabetes mellitus in a patient with congenital hyperinsulinaemic hypoglycaemia due to autosomal dominant ABCC8 mutation. J Pediatr Endocrinol Metab. 2017;30(11):1219\u201322.","journal-title":"J Pediatr Endocrinol Metab"},{"issue":"12","key":"9548_CR148","doi-asserted-by":"crossref","first-page":"4719","DOI":"10.1210\/jc.2016-2711","volume":"101","author":"M Szymanowski","year":"2016","unstructured":"Szymanowski M, Estebanez MS, Padidela R, Han B, Mosinska K, Stevens A, et al. mTOR inhibitors for the treatment of severe congenital Hyperinsulinism: perspectives on limited therapeutic success. J Clin Endocrinol Metab. 2016;101(12):4719\u201329.","journal-title":"J Clin Endocrinol Metab"},{"issue":"1","key":"9548_CR149","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1186\/s13023-017-0621-5","volume":"12","author":"I Banerjee","year":"2017","unstructured":"Banerjee I, De Leon D, Dunne MJ. Extreme caution on the use of sirolimus for the congenital hyperinsulinism in infancy patient. Orphanet J Rare Dis. 2017;12(1):70.","journal-title":"Orphanet J Rare Dis"},{"issue":"4","key":"9548_CR150","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1210\/js.2018-00417","volume":"3","author":"G Maria","year":"2019","unstructured":"Maria G, Antonia D, Michael A, Kate M, Sian E, Sarah FE, et al. Sirolimus: efficacy and complications in children with Hyperinsulinemic hypoglycemia: a 5-year follow-up study. J Endocr Soc. 2019;3(4):699\u2013713.","journal-title":"J Endocr Soc"},{"issue":"3","key":"9548_CR151","doi-asserted-by":"crossref","first-page":"889","DOI":"10.1677\/joe.1.06949","volume":"190","author":"NH McClenaghan","year":"2006","unstructured":"McClenaghan NH, Flatt PR, Ball AJ. Actions of glucagon-like peptide-1 on KATP channel-dependent and -independent effects of glucose, sulphonylureas and nateglinide. J Endocrinol. 2006;190(3):889\u201396.","journal-title":"J Endocrinol"},{"issue":"38","key":"9548_CR152","doi-asserted-by":"crossref","first-page":"25786","DOI":"10.1074\/jbc.M804372200","volume":"283","author":"DD De Le\u00f3n","year":"2008","unstructured":"De Le\u00f3n DD, et al. Exendin-(9-39) corrects fasting hypoglycemia in SUR-1\u2212\/\u2212 mice by lowering cAMP in pancreatic beta-cells and inhibiting insulin secretion. J Biol Chem. 2008;283(38):25786\u201393.","journal-title":"J Biol Chem"},{"issue":"10","key":"9548_CR153","doi-asserted-by":"crossref","first-page":"2585","DOI":"10.2337\/db12-0166","volume":"61","author":"AC Calabria","year":"2012","unstructured":"Calabria AC, Li C, Gallagher PR, Stanley CA, de Le\u00f3n DD. GLP-1 receptor antagonist exendin-(9-39) elevates fasting blood glucose levels in congenital hyperinsulinism owing to inactivating mutations in the ATP-sensitive K+ channel. Diabetes. 2012;61(10):2585\u201391.","journal-title":"Diabetes"},{"issue":"29","key":"9548_CR154","doi-asserted-by":"crossref","first-page":"20942","DOI":"10.1074\/jbc.M113.470948","volume":"288","author":"PC Chen","year":"2013","unstructured":"Chen PC, Olson EM, Zhou Q, Kryukova Y, Sampson HM, Thomas DY, et al. Carbamazepine as a novel small molecule corrector of trafficking-impaired ATP-sensitive potassium channels identified in congenital hyperinsulinism. J Biol Chem. 2013;288(29):20942\u201354.","journal-title":"J Biol Chem"},{"issue":"12","key":"9548_CR155","doi-asserted-by":"crossref","first-page":"11096","DOI":"10.1074\/jbc.M312810200","volume":"279","author":"F Yan","year":"2004","unstructured":"Yan F, Lin CW, Weisiger E, Cartier EA, Taschenberger G, Shyng SL. Sulfonylureas correct trafficking defects of ATP-sensitive potassium channels caused by mutations in the sulfonylurea receptor. J Biol Chem. 2004;279(12):11096\u2013105.","journal-title":"J Biol Chem"},{"issue":"12","key":"9548_CR156","doi-asserted-by":"crossref","first-page":"7980","DOI":"10.1074\/jbc.M114.634576","volume":"290","author":"PK Devaraneni","year":"2015","unstructured":"Devaraneni PK, Martin GM, Olson EM, Zhou Q, Shyng SL. Structurally distinct ligands rescue biogenesis defects of the KATP channel complex via a converging mechanism. J Biol Chem. 2015;290(12):7980\u201391.","journal-title":"J Biol Chem"},{"issue":"42","key":"9548_CR157","doi-asserted-by":"crossref","first-page":"21971","DOI":"10.1074\/jbc.M116.749366","volume":"291","author":"GM Martin","year":"2016","unstructured":"Martin GM, Rex EA, Devaraneni P, Denton JS, Boodhansingh KE, DeLeon D, et al. Pharmacological correction of trafficking defects in ATP-sensitive potassium channels caused by sulfonylurea receptor 1 mutations. J Biol Chem. 2016;291(42):21971\u201383.","journal-title":"J Biol Chem"},{"issue":"11\u201312","key":"9548_CR158","first-page":"1157","volume":"26","author":"OM Neylon","year":"2013","unstructured":"Neylon OM, Moran MM, Pellicano A, Nightingale M, O'Connell MA. Successful subcutaneous glucagon use for persistent hypoglycaemia in congenital hyperinsulinism. J Pediatr Endocrinol Metab. 2013;26(11\u201312):1157\u201361.","journal-title":"J Pediatr Endocrinol Metab"},{"issue":"3","key":"9548_CR159","doi-asserted-by":"crossref","first-page":"531","DOI":"10.2337\/dc17-1402","volume":"41","author":"U H\u00f6velmann","year":"2018","unstructured":"H\u00f6velmann U, Bysted BV, Mouritzen U, Macchi F, Lamers D, Kronshage B, et al. Pharmacokinetic and Pharmacodynamic characteristics of Dasiglucagon, a novel soluble and stable glucagon analog. Diabetes Care. 2018;41(3):531\u20137.","journal-title":"Diabetes Care"},{"issue":"2","key":"9548_CR160","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1089\/dia.2017.0298","volume":"20","author":"AJ Laguna Sanz","year":"2018","unstructured":"Laguna Sanz AJ, Mulla CM, Fowler KM, Cloutier E, Goldfine AB, Newswanger B, et al. Design and clinical evaluation of a novel low-glucose prediction algorithm with mini-dose stable glucagon delivery in post-bariatric hypoglycemia. Diabetes Technol Ther. 2018;20(2):127\u201339.","journal-title":"Diabetes Technol Ther"},{"issue":"1","key":"9548_CR161","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1053\/j.sempedsurg.2010.10.009","volume":"20","author":"A Pierro","year":"2011","unstructured":"Pierro A, Nah SA. Surgical management of congenital hyperinsulinism of infancy. Semin Pediatr Surg. 2011;20(1):50\u20133.","journal-title":"Semin Pediatr Surg"},{"issue":"3","key":"9548_CR162","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1016\/j.jpedsurg.2003.11.019","volume":"39","author":"NS Adzick","year":"2004","unstructured":"Adzick NS, Thornton PS, Stanley CA, Kaye RD, Ruchelli E. A multidisciplinary approach to the focal form of congenital hyperinsulinism leads to successful treatment by partial pancreatectomy. J Pediatr Surg. 2004;39(3):270\u20135.","journal-title":"J Pediatr Surg"},{"issue":"5","key":"9548_CR163","doi-asserted-by":"crossref","first-page":"957","DOI":"10.1016\/j.jpedsurg.2009.01.042","volume":"44","author":"S Al-Shanafey","year":"2009","unstructured":"Al-Shanafey S. Laparoscopic vs open pancreatectomy for persistent hyperinsulinemic hypoglycemia of infancy. J Pediatr Surg. 2009;44(5):957\u201361.","journal-title":"J Pediatr Surg"},{"issue":"1","key":"9548_CR164","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1016\/j.jpedsurg.2011.10.032","volume":"47","author":"P Laje","year":"2012","unstructured":"Laje P, et al. Pancreatic head resection and roux-en-Y pancreaticojejunostomy for the treatment of the focal form of congenital hyperinsulinism. J Pediatr Surg. 2012;47(1):130\u20135.","journal-title":"J Pediatr Surg"},{"issue":"2","key":"9548_CR165","doi-asserted-by":"crossref","first-page":"198","DOI":"10.2337\/dc11-1296","volume":"35","author":"J Beltrand","year":"2012","unstructured":"Beltrand J, Caquard M, Arnoux JB, Laborde K, Velho G, Verkarre V, et al. Glucose metabolism in 105 children and adolescents after pancreatectomy for congenital hyperinsulinism. Diabetes Care. 2012;35(2):198\u2013203.","journal-title":"Diabetes Care"},{"issue":"5","key":"9548_CR166","volume":"9","author":"VB Arya","year":"2014","unstructured":"Arya VB, Senniappan S, Demirbilek H, Alam S, Flanagan SE, Ellard S, et al. Pancreatic endocrine and exocrine function in children following near-total pancreatectomy for diffuse congenital hyperinsulinism. PLoS One. 2014;9(5):e98054.","journal-title":"PLoS One"},{"issue":"2","key":"9548_CR167","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1053\/j.sempedsurg.2014.03.005","volume":"23","author":"P Shah","year":"2014","unstructured":"Shah P, Demirbilek H, Hussain K. Persistent hyperinsulinaemic hypoglycaemia in infancy. Semin Pediatr Surg. 2014;23(2):76\u201382.","journal-title":"Semin Pediatr Surg"},{"issue":"4","key":"9548_CR168","doi-asserted-by":"crossref","first-page":"987","DOI":"10.2214\/ajr.181.4.1810987","volume":"181","author":"H Gouya","year":"2003","unstructured":"Gouya H, Vignaux O, Augui J, Dousset B, Palazzo L, Louvel A, et al. CT, endoscopic sonography, and a combined protocol for preoperative evaluation of pancreatic insulinomas. AJR Am J Roentgenol. 2003;181(4):987\u201392.","journal-title":"AJR Am J Roentgenol"},{"issue":"7","key":"9548_CR169","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1016\/j.endonu.2015.04.004","volume":"62","author":"P Iglesias","year":"2015","unstructured":"Iglesias P, Lafuente C, Mart\u00edn Almendra M\u00c1, L\u00f3pez Guzm\u00e1n A, Castro JC, D\u00edez JJ. Insulinoma: a multicenter, retrospective analysis of three decades of experience (1983-2014). Endocrinol Nutr. 2015;62(7):306\u201313.","journal-title":"Endocrinol Nutr"},{"issue":"6","key":"9548_CR170","doi-asserted-by":"crossref","first-page":"829","DOI":"10.3748\/wjg.v19.i6.829","volume":"19","author":"T Okabayashi","year":"2013","unstructured":"Okabayashi T, Shima Y, Sumiyoshi T, Kozuki A, Ito S, Ogawa Y, et al. Diagnosis and management of insulinoma. World J Gastroenterol. 2013;19(6):829\u201337.","journal-title":"World J Gastroenterol"},{"issue":"16","key":"9548_CR171","doi-asserted-by":"crossref","first-page":"1197","DOI":"10.4253\/wjge.v7.i16.1197","volume":"7","author":"PT Antonakis","year":"2015","unstructured":"Antonakis PT, Ashrafian H, Martinez-Isla A. Pancreatic insulinomas: laparoscopic management. World J Gastrointest Endosc. 2015;7(16):1197\u2013207.","journal-title":"World J Gastrointest Endosc"},{"issue":"6","key":"9548_CR172","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1016\/j.bpg.2012.12.003","volume":"26","author":"T Ito","year":"2012","unstructured":"Ito T, Igarashi H, Jensen RT. Pancreatic neuroendocrine tumors: clinical features, diagnosis and medical treatment: advances. Best Pract Res Clin Gastroenterol. 2012;26(6):737\u201353.","journal-title":"Best Pract Res Clin Gastroenterol"},{"issue":"1","key":"9548_CR173","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1186\/s13023-016-0547-3","volume":"11","author":"M Salomon-Estebanez","year":"2016","unstructured":"Salomon-Estebanez M, Flanagan SE, Ellard S, Rigby L, Bowden L, Mohamed Z, et al. Conservatively treated congenital Hyperinsulinism (CHI) due to K-ATP channel gene mutations: reducing severity over time. Orphanet J Rare Dis. 2016;11(1):163.","journal-title":"Orphanet J Rare Dis"},{"key":"9548_CR174","doi-asserted-by":"crossref","unstructured":"Sun L, Coy DH. Somatostatin and its analogs. Curr Drug Targets. 2016;17(9):529\u2013537.","DOI":"10.2174\/1389450116666141205163548"},{"issue":"10","key":"9548_CR175","doi-asserted-by":"crossref","first-page":"3660","DOI":"10.1210\/jc.2014-1866","volume":"99","author":"H Demirbilek","year":"2014","unstructured":"Demirbilek H, Shah P, Arya VB, Hinchey L, Flanagan SE, Ellard S, et al. Long-term follow-up of children with congenital hyperinsulinism on octreotide therapy. J Clin Endocrinol Metab. 2014;99(10):3660\u20137.","journal-title":"J Clin Endocrinol Metab"},{"issue":"11","key":"9548_CR176","doi-asserted-by":"crossref","first-page":"4133","DOI":"10.1210\/jc.2015-2539","volume":"100","author":"K Lord","year":"2015","unstructured":"Lord K, et al. High risk of diabetes and neurobehavioral deficits in individuals with surgically treated Hyperinsulinism. J Clin Endocrinol Metab. 2015;100(11):4133\u20139.","journal-title":"J Clin Endocrinol Metab"},{"issue":"1","key":"9548_CR177","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1159\/000481774","volume":"89","author":"A Ludwig","year":"2018","unstructured":"Ludwig A, et al. Formal neurocognitive testing in 60 patients with congenital Hyperinsulinism. Horm Res Paediatr. 2018;89(1):1\u20136.","journal-title":"Horm Res Paediatr"},{"key":"9548_CR178","unstructured":"NICE, NG43. Transition from children\u2019s to adults\u2019 services for young people using health or social care services. https:\/\/www.nice.org.uk\/guidance\/ng43\/resources. Accessed 1 Feb 2016."},{"issue":"4","key":"9548_CR179","doi-asserted-by":"crossref","first-page":"e1062","DOI":"10.1542\/peds.2012-1450","volume":"131","author":"DS Lotstein","year":"2013","unstructured":"Lotstein DS, et al. Transition from pediatric to adult care for youth diagnosed with type 1 diabetes in adolescence. Pediatrics. 2013;131(4):e1062\u201370.","journal-title":"Pediatrics"},{"issue":"3","key":"9548_CR180","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1136\/adc.81.3.271","volume":"81","author":"R Viner","year":"1999","unstructured":"Viner R. Transition from paediatric to adult care. Bridging the gaps or passing the buck? Arch Dis Child. 1999;81(3):271\u20135.","journal-title":"Arch Dis Child"},{"issue":"21\u201322","key":"9548_CR181","doi-asserted-by":"crossref","first-page":"3113","DOI":"10.1111\/jocn.13326","volume":"25","author":"H Zhou","year":"2016","unstructured":"Zhou H, Roberts P, Dhaliwal S, Della P. Transitioning adolescent and young adults with chronic disease and\/or disabilities from paediatric to adult care services - an integrative review. J Clin Nurs. 2016;25(21\u201322):3113\u201330.","journal-title":"J Clin Nurs"},{"issue":"8","key":"9548_CR182","doi-asserted-by":"crossref","first-page":"1458","DOI":"10.1097\/MIB.0000000000000045","volume":"20","author":"PS de Silva","year":"2014","unstructured":"de Silva PS, Fishman LN. Transition of the patient with IBD from pediatric to adult care-an assessment of current evidence. Inflamm Bowel Dis. 2014;20(8):1458\u201364.","journal-title":"Inflamm Bowel Dis"},{"issue":"4","key":"9548_CR183","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1097\/MOP.0b013e32833a46a7","volume":"22","author":"JS Borus","year":"2010","unstructured":"Borus JS, Laffel L. Adherence challenges in the management of type 1 diabetes in adolescents: prevention and intervention. Curr Opin Pediatr. 2010;22(4):405\u201311.","journal-title":"Curr Opin Pediatr"},{"issue":"2","key":"9548_CR184","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1093\/jpepsy\/jsp051","volume":"36","author":"JM Valenzuela","year":"2011","unstructured":"Valenzuela JM, Buchanan CL, Radcliffe J, Ambrose C, Hawkins LA, Tanney M, et al. Transition to adult services among behaviorally infected adolescents with HIV--a qualitative study. J Pediatr Psychol. 2011;36(2):134\u201340.","journal-title":"J Pediatr Psychol"},{"issue":"3","key":"9548_CR185","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1097\/NUR.0b013e31828c8372","volume":"27","author":"KM Hanna","year":"2013","unstructured":"Hanna KM, Woodward J. The transition from pediatric to adult diabetes care services. Clin Nurse Spec. 2013;27(3):132\u201345.","journal-title":"Clin Nurse Spec"},{"issue":"6","key":"9548_CR186","doi-asserted-by":"crossref","first-page":"796","DOI":"10.1016\/j.jadohealth.2014.06.008","volume":"55","author":"A van Staa","year":"2014","unstructured":"van Staa A, Sattoe JN. Young adults' experiences and satisfaction with the transfer of care. J Adolesc Health. 2014;55(6):796\u2013803.","journal-title":"J Adolesc Health"},{"issue":"2","key":"9548_CR187","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/S0738-3991(02)00032-0","volume":"48","author":"J Barlow","year":"2002","unstructured":"Barlow J, et al. Self-management approaches for people with chronic conditions: a review. Patient Educ Couns. 2002;48(2):177\u201387.","journal-title":"Patient Educ Couns"},{"issue":"4","key":"9548_CR188","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2016-014593","volume":"7","author":"M Acu\u00f1a Mora","year":"2017","unstructured":"Acu\u00f1a Mora M, Sparud-Lundin C, Bratt EL, Moons P. Person-centred transition programme to empower adolescents with congenital heart disease in the transition to adulthood: a study protocol for a hybrid randomised controlled trial (STEPSTONES project). BMJ Open. 2017;7(4):e014593.","journal-title":"BMJ Open"},{"issue":"4","key":"9548_CR189","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1016\/j.psc.2007.07.009","volume":"30","author":"S Turkel","year":"2007","unstructured":"Turkel S, Pao M. Late consequences of chronic pediatric illness. Psychiatr Clin North Am. 2007;30(4):819\u201335.","journal-title":"Psychiatr Clin North Am"},{"issue":"11","key":"9548_CR190","doi-asserted-by":"crossref","first-page":"2477","DOI":"10.2337\/dc11-1723","volume":"34","author":"A Peters","year":"2011","unstructured":"Peters A, Laffel L, A.D.A.T.W. Group. Diabetes care for emerging adults: recommendations for transition from pediatric to adult diabetes care systems: a position statement of the American Diabetes Association, with representation by the American College of Osteopathic Family Physicians, the American Academy of Pediatrics, the American Association of Clinical Endocrinologists, the American Osteopathic Association, the Centers for Disease Control and Prevention, Children with Diabetes, The Endocrine Society, the International Society for Pediatric and Adolescent Diabetes, Juvenile Diabetes Research Foundation International, the National Diabetes Education Program, and the Pediatric Endocrine Society (formerly Lawson Wilkins Pediatric Endocrine Society). Diabetes Care. 2011;34(11):2477\u201385.","journal-title":"Diabetes Care"},{"issue":"4","key":"9548_CR191","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1007\/s00125-018-4566-6","volume":"61","author":"P Choudhary","year":"2018","unstructured":"Choudhary P, Amiel SA. Hypoglycaemia in type 1 diabetes: technological treatments, their limitations and the place of psychology. Diabetologia. 2018;61(4):761\u20139.","journal-title":"Diabetologia"},{"issue":"4","key":"9548_CR192","doi-asserted-by":"crossref","first-page":"517","DOI":"10.2337\/diacare.18.4.517","volume":"18","author":"WL Clarke","year":"1995","unstructured":"Clarke WL, Cox DJ, Gonder-Frederick LA, Julian D, Schlundt D, Polonsky W. Reduced awareness of hypoglycemia in adults with IDDM. A prospective study of hypoglycemic frequency and associated symptoms. Diabetes Care. 1995;18(4):517\u201322.","journal-title":"Diabetes Care"},{"issue":"7","key":"9548_CR193","doi-asserted-by":"crossref","first-page":"697","DOI":"10.2337\/diacare.17.7.697","volume":"17","author":"AE Gold","year":"1994","unstructured":"Gold AE, MacLeod KM, Frier BM. Frequency of severe hypoglycemia in patients with type I diabetes with impaired awareness of hypoglycemia. Diabetes Care. 1994;17(7):697\u2013703.","journal-title":"Diabetes Care"},{"issue":"5","key":"9548_CR194","doi-asserted-by":"crossref","first-page":"612","DOI":"10.1016\/j.jpeds.2009.06.044","volume":"155","author":"WW Hay","year":"2009","unstructured":"Hay WW, et al. Knowledge gaps and research needs for understanding and treating neonatal hypoglycemia: workshop report from Eunice Kennedy Shriver National Institute of Child Health and Human Development. J Pediatr. 2009;155(5):612\u20137.","journal-title":"J Pediatr"},{"key":"9548_CR195","unstructured":"DVLA Assessing fitness to drive \u2013 a guide for medical. professionals [Internet]. May 20, 2018."},{"issue":"7606","key":"9548_CR196","doi-asserted-by":"crossref","first-page":"1231","DOI":"10.1136\/bmj.39232.425197.BE","volume":"334","author":"C Wallis","year":"2007","unstructured":"Wallis C. Transition of care in children with chronic disease. BMJ. 2007;334(7606):1231\u20132.","journal-title":"BMJ"},{"issue":"8","key":"9548_CR197","doi-asserted-by":"crossref","first-page":"1080","DOI":"10.1016\/j.apmr.2007.06.001","volume":"88","author":"P Rosenbaum","year":"2007","unstructured":"Rosenbaum P, Stewart D. Perspectives on transitions: rethinking services for children and youth with developmental disabilities. Arch Phys Med Rehabil. 2007;88(8):1080\u20132.","journal-title":"Arch Phys Med Rehabil"},{"key":"9548_CR198","doi-asserted-by":"crossref","unstructured":"Cannarella R, Arato I, Condorelli RA, et  al. Effects of insulin on porcine neonatal sertoli cell responsiveness to FSH In Vitro. J Clin Med. 2019;8(6):809.","DOI":"10.3390\/jcm8060809"},{"issue":"6","key":"9548_CR199","doi-asserted-by":"crossref","first-page":"946","DOI":"10.4158\/EP13109.OR","volume":"19","author":"KC Garvey","year":"2013","unstructured":"Garvey KC, Wolpert HA, Laffel LM, Rhodes ET, Wolfsdorf JI, Finkelstein JA. Health care transition in young adults with type 1 diabetes: barriers to timely establishment of adult diabetes care. Endocr Pract. 2013;19(6):946\u201352.","journal-title":"Endocr Pract"},{"issue":"4","key":"9548_CR200","doi-asserted-by":"crossref","first-page":"656","DOI":"10.1111\/pedi.12638","volume":"19","author":"SR Johnson","year":"2018","unstructured":"Johnson SR, Leo PJ, McInerney-Leo A, Anderson LK, Marshall M, McGown I, et al. Whole-exome sequencing for mutation detection in pediatric disorders of insulin secretion: maturity onset diabetes of the young and congenital hyperinsulinism. Pediatr Diabetes. 2018;19(4):656\u201362.","journal-title":"Pediatr Diabetes"},{"issue":"9","key":"9548_CR201","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1016\/S2213-8587(16)30323-0","volume":"5","author":"P Shah","year":"2017","unstructured":"Shah P, et al. Hyperinsulinaemic hypoglycaemia in children and adults. Lancet Diabetes Endocrinol. 2017;5(9):729\u201342.","journal-title":"Lancet Diabetes Endocrinol"},{"issue":"1","key":"9548_CR202","doi-asserted-by":"crossref","first-page":"262","DOI":"10.4161\/mabs.26871","volume":"6","author":"JA Corbin","year":"2014","unstructured":"Corbin JA, Bhaskar V, Goldfine ID, Issafras H, Bedinger DH, Lau A, et al. Inhibition of insulin receptor function by a human, allosteric monoclonal antibody: a potential new approach for the treatment of hyperinsulinemic hypoglycemia. MAbs. 2014;6(1):262\u201372.","journal-title":"MAbs"},{"key":"9548_CR203","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1159\/000207480","volume":"14","author":"RR Kapoor","year":"2009","unstructured":"Kapoor RR, James C, Hussain K. Hyperinsulinism in developmental syndromes. Endocr Dev. 2009;14:95\u2013113.","journal-title":"Endocr Dev"}],"container-title":["Reviews in Endocrine and Metabolic Disorders"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11154-020-09548-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s11154-020-09548-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11154-020-09548-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,3,16]],"date-time":"2021-03-16T20:30:23Z","timestamp":1615926623000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11154-020-09548-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,3,17]]},"references-count":203,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2020,12]]}},"alternative-id":["9548"],"URL":"https:\/\/doi.org\/10.1007\/s11154-020-09548-7","relation":{},"ISSN":["1389-9155","1573-2606"],"issn-type":[{"value":"1389-9155","type":"print"},{"value":"1573-2606","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,3,17]]},"assertion":[{"value":"17 March 2020","order":1,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"Nick Oliver has received honoraria for advisory board participation or speaking from Dexcom, Roche diabetes, and Medtronic diabetes; support for education from Novo Nordisk and Takeda; and research funding from Dexcom and Roche diabetes. The other authors have no information to disclose.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"Sarah Flanagan is supported by a Sir Henry Dale Fellowship jointly funded by the Wellcome Trust and the Royal Society (105,636\/Z\/14\/Z). The other authors are not supported by grants or fellowships.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Grants and fellowships supporting the writing of the paper"}}]}}